11
May

08:00 AM PDT

Clinical Operations
Strategy Meeting West Coast USA 2023

The premier meeting for all West Coast USA Clinical Operations professionals

Hard Rock Hotel San Diego

A MEETING EXPERIENCE UNLIKE ANY OTHER

Fresh Clinical Operations Insights

Tired of the same conference experience? Real discussions and genuine networking are often promised, but not always delivered.

Proventa International’s Clinical Strategy Meetings are designed to avoid the pitfalls of a typical conference, by providing the right environment to make those important connections through interactive roundtable discussions, exclusive networking and keynote panel debates. Join Clinical Operations professionals from across the West Coast in San Diego, to discover new insights and take your company’s mission to the next level.

What makes our strategy meetings unique?

Roundtable Discussions

Intimate discussions led by renowned industry experts. Have your voice heard and debate alongside like-minded life science executives.

Unrivalled Networking

With senior delegation from big pharma and innovative biotech from across the West Coast, you can network with peers from different locations, all in one place.

Personalised Agenda

Choose the topics that matter to you. Reserve your place at the roundtable discussions and ensure your whole day delivers the insights you need to hear.

Solutions to your Problems

We’ve partnered with the best solution providers to solve your biggest challenges. Engage in pre-arranged, private meetings to address your specific needs and find a tangible solution.

Industry Researched Topics

We guarantee our agenda is up-to-date and mission critical because its designed by you. We speak to our extended network of senior decision makers to ensure the most important topics are discussed.

Senior Decision Makers

The entire strategy meeting is specifically tailored to the needs and challenges of senior life science professionals. Discover how your peers are dealing with the same challenges as you.

Meet Our Facilitator

Our panel of facilitators play a key role in shaping the agenda for the day. See who will be bringing their expertise to the table at Clinical Operations Strategy Meetings.

Ali Vozza

Manager of Clinical Affairs Epigenomics

Ana Krtolica

Vice President, Global Research & Development Retrotope Inc.

Angela Pietrofeso

Vice President, Clinical Development Operations Oncternal Therapeutics

Alejandra Maciel

Vice President, Clinical Affairs Epigenomics

Ben Cadieux

Vice President of Medical Affairs MEI Pharma

Bonne Adams

Chief Operating Officer Tracon Tracon Pharmaceuticals

Doniel Jackson

Vice President of Drug Safety and Pharmacovigilance MEI Pharma

Jack Florio

Managing Director Weild & Co

Kat Murphy

Senior Director, Clinical Operations Arcturus Therapeutics

Tara Lehner

VP Clinical Operations INmune Bio

Melody Anderson

Executive Director, Clinical Operations Avelas Biosciences

Moya Daniels

SVP, Regulatory Affairs, Clinical Operations and Quality Indapta Therapeutics

Dr. Udayasankar Arulmani

Vice President, Global Clinical Development and Operations Santen Pharmaceuticals

Dr. Uday Arulmani is currently employed in Santen as VP Global Clinical Development and Operations (GCDO). Dr. Uday Arulmani is the clinical trial officer for Santen Pharmaceuticals which is a renowned company specializing in ophthalmic drugs worldwide.
Dr. Uday Arulmani received his medical degree from Madras Medical College, Madras, India. Following his medical degree, he completed his senior residency in Rheumatology and Immunology in Government General Hospital in Madras, India.
In 2000, Dr. Arulmani was awarded a Dutch fellowship to pursue his Master’s in Clinical Epidemiology at the Erasmus Medical Center, Rotterdam, The Netherlands. Following his successful completion of Master’s degree, he continued his PhD in clinical pharmacology.  In addition, Dr. Arulmani received his MBA education from Heriott Watt University, Edinburgh.
Dr. Uday Arulmani has 15 years of pharmaceutical industry experience at major pharmaceutical
companies. He has been serving most recently as a Senior Director, Clinical research in Gilead sciences where he has led the inflammatory bowel disease programs. Previously, he served in different leadership positions at Genentech, Abbvie/Abbott and Novartis Pharma AG (Basel, Switzerland).  Dr. Uday Arulmani has published several peer reviewed articles in international journals and abstracts in major international conferences.  
Dr. Arulmani is passionate in decentralized clinical trials, digital technology and artificial intelligence in clinical development.

Sagar Vaidya

Vice President of Clinical Development Travere Therapeutics

See the agenda and facilitator line-up Download the strategy meeting brochure for full details

DOWNLOAD THE BROCHURE

Reasons To Attend Our Strategy Meetings

Fully Interactive Format

There’s only so much you can learn from presentations and lectures. Instead our interactive Roundtable Discussions let you debate the topics that really matter

Senior Decision Makers

All our Strategy Meetings are aimed at director level and above. Discover how your peers are tackling the industries biggest challenges and have your thoughts heard

Personalised Agendas

Pick the roundtable discussions that you want to be part of. Simply choose your sessions and we’ll create a personalised agenda just for you

Private and Intimate Networking

Small group discussions, private meetings, networking drinks – however you choose to make those important connections our Strategy Meetings have the solution